{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:23:04Z","timestamp":1792794184907,"version":"4.5.0"},"reference-count":67,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,10]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is an inherited red blood cell disorder with significant complications, including vaso-occlusive crisis (VOC), the most common cause of emergency department (ED) visits and hospitalizations. Pain in children with SCD is often underestimated. We evaluated the impact of a standardized institutional nurse\u2013initiated ED SCD pain protocol, using intranasal (IN) fentanyl (INF) as the initial agent, on hospital admission rates. We conducted a preintervention\/postintervention study of patients with SCD (aged 0-21 years) presenting to a quaternary pediatric ED for uncomplicated VOC pain from June 2015 to December 2019. Overall, 162 patients accounted for 471 ED visits in the preintervention period and 80 patients accounted for 162 visits in the postintervention period. After intervention, hospitalization rates (P = .0017) and inpatient length of stay (P = .0019) decreased, but median pain scores at presentation (P = .0047) and discharge (P = .1451) remained comparable. The time to initial analgesia dose significantly improved in the postintervention (P&amp;lt; .0001), along with the time from physician order to initial analgesia administration (P = .0005). IV and IN analgesia use rose significantly in the postintervention (odds ratio, 4.7; P&amp;lt; .0001), with INF being the preferred analgesic agent (61%) and a corresponding reduction in oral analgesic use (P&amp;lt; .0001). In an ad hoc sustainability analysis, INF use remained high and time to first dose was sustained. Implementing a standardized ED SCD pain protocol improved timeliness and consistency in analgesia administration and decreased overall hospitalization rates. This study also highlights the role of INF as an effective initial analgesic within standardized ED protocols for pediatric VOC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016309","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T19:37:12Z","timestamp":1761334632000},"page":"802-812","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["Intranasal fentanyl and impact of an emergency department pain protocol for sickle cell disease on hospitalization rates"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7723-8936","authenticated-orcid":false,"given":"Olufunke Y.","family":"Martin","sequence":"first","affiliation":[{"name":"1Division of Pediatric Hematology and Oncology, Center for Cancer and Blood Disorders, Children's Medical Center, The University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7160-9961","authenticated-orcid":false,"given":"Sean M.","family":"Thompson","sequence":"additional","affiliation":[{"name":"2Division of Pediatric Emergency Medicine, Department of Emergency Medicine, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3661-2689","authenticated-orcid":false,"given":"Matthew","family":"Hays","sequence":"additional","affiliation":[{"name":"3Department of Biostatistics and Health Data Science, Indiana University School of Medicine and Richard M. Fairbanks School of Public Health, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-6102","authenticated-orcid":false,"given":"Seethal A.","family":"Jacob","sequence":"additional","affiliation":[{"name":"4Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Riley Children\u2019s Health, Indianapolis, IN"},{"name":"5Division of Children\u2019s Health Services Research, Indiana University School of Medicine, Indianapolis, IN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"issue":"suppl 4","key":"2026021015524480600_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"9","key":"2026021015524480600_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7109a1","article-title":"Surveillance for sickle cell disease - sickle cell data collection program, two states, 2004-2018","volume":"71","author":"Snyder","year":"2022","journal-title":"MMWR Surveill Summ"},{"issue":"9861","key":"2026021015524480600_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"2026021015524480600_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0950-3536(98)80074-7","article-title":"Pathophysiology of sickle cell disease","volume":"11","author":"Steinberg","year":"1998","journal-title":"Baillieres Clin Haematol"},{"issue":"2","key":"2026021015524480600_bib5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood.V77.2.214.214","article-title":"Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology","volume":"77","author":"Hebbel","year":"1991","journal-title":"Blood"},{"issue":"1","key":"2026021015524480600_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0268-960X(96)90018-1","article-title":"The pathophysiology of vascular obstruction in the sickle syndromes","volume":"10","author":"Kaul","year":"1996","journal-title":"Blood Rev"},{"issue":"2","key":"2026021015524480600_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/10739680490279410","article-title":"Sickle red cell microrheology and sickle blood rheology","volume":"11","author":"Ballas","year":"2004","journal-title":"Microcirculation"},{"issue":"1","key":"2026021015524480600_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1182\/asheducation-2017.1.412","article-title":"Improving emergency department-based care of sickle cell pain","volume":"2017","author":"Glassberg","year":"2017","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"2","key":"2026021015524480600_bib9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TME.0000000000000099","article-title":"Evaluation of a sickle cell disease educational website for emergency providers","volume":"38","author":"Kayle","year":"2016","journal-title":"Adv Emerg Nurs J"},{"issue":"6","key":"2026021015524480600_bib10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3109\/03630269509005824","article-title":"The sickle cell painful crisis in adults: phases and objective signs","volume":"19","author":"Ballas","year":"1995","journal-title":"Hemoglobin"},{"issue":"6","key":"2026021015524480600_bib11","doi-asserted-by":"crossref","first-page":"e28067","DOI":"10.1002\/pbc.28067","article-title":"Variation in hospital admission of sickle cell patients from the emergency department using the Pediatric Health Information System","volume":"67","author":"Jacob","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2026021015524480600_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/pbc.22069","article-title":"Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States","volume":"53","author":"Mvundura","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2026021015524480600_bib13","first-page":"44","article-title":"Hospital utilization patterns and costs for adult sickle cell patients in Illinois","volume":"112","author":"Woods","year":"1997","journal-title":"Public Health Rep"},{"issue":"10","key":"2026021015524480600_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"2026021015524480600_bib15","doi-asserted-by":"crossref","first-page":"100158","DOI":"10.1016\/j.focus.2023.100158","article-title":"Characteristics of emergency department visits made by individuals with sickle cell disease in the U.S., 1999-2020","volume":"3","author":"Attell","year":"2024","journal-title":"AJPM Focus"},{"issue":"4 suppl","key":"2026021015524480600_bib16","doi-asserted-by":"crossref","first-page":"S550","DOI":"10.1016\/j.amepre.2010.01.004","article-title":"Sickle cell disease-related pediatric medical expenditures in the U.S","volume":"38","author":"Amendah","year":"2010","journal-title":"Am J Prev Med"},{"issue":"3","key":"2026021015524480600_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.emc.2014.04.011","article-title":"Sickle cell disease in the emergency department","volume":"32","author":"Lovett","year":"2014","journal-title":"Emerg Med Clin North Am"},{"issue":"3","key":"2026021015524480600_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1542\/peds.2014-2874","article-title":"Timing of opioid administration as a quality indicator for pain crises in sickle cell disease","volume":"135","author":"Mathias","year":"2015","journal-title":"Pediatrics"},{"key":"2026021015524480600_bib19","unstructured":"National Heart, Lung, and Blood Institute\n          . Evidence-based management of sickle cell disease: expert panel report. 2014. Accessed 20 January 2025. https:\/\/www.nhlbi.nih.gov\/resources\/evidence-based-management-sickle-cell-disease-expert-panel-report-2014."},{"issue":"12","key":"2026021015524480600_bib20","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"issue":"8","key":"2026021015524480600_bib21","first-page":"1","article-title":"Evidence-based management of sickle cell disease in the emergency department","volume":"13","author":"Glassberg","year":"2011","journal-title":"Emerg Med Pract"},{"issue":"5","key":"2026021015524480600_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/pm\/pnx019","article-title":"The ACTTION-APS-AAPM Pain taxonomy (AAAPT) multidimensional approach to classifying acute pain conditions","volume":"18","author":"Kent","year":"2017","journal-title":"Pain Med"},{"issue":"5","key":"2026021015524480600_bib23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1553-2712.2007.tb01801.x","article-title":"Emergency department management of acute pain episodes in sickle cell disease","volume":"14","author":"Tanabe","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"1","key":"2026021015524480600_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/PEC.0b013e318203ca03","article-title":"Pain scores: are they used in sickle cell pain?","volume":"27","author":"Zempsky","year":"2011","journal-title":"Pediatr Emerg Care"},{"issue":"4","key":"2026021015524480600_bib25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajem.2012.11.005","article-title":"The impact of race and disease on sickle cell patient wait times in the emergency department","volume":"31","author":"Haywood","year":"2013","journal-title":"Am J Emerg Med"},{"issue":"6","key":"2026021015524480600_bib26","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/MPH.0000000000001843","article-title":"Emergency department provider survey regarding acute sickle cell pain management","volume":"42","author":"Martin","year":"2020","journal-title":"J Pediatr Hematol Oncol"},{"issue":"5","key":"2026021015524480600_bib27","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.55730\/1300-0144.5897","article-title":"Management of acute pain in adults with sickle cell disease: the experience of the Clinical Hematology Department of the University of Dakar","volume":"54","author":"Diallo","year":"2024","journal-title":"Turk J Med Sci"},{"issue":"5","key":"2026021015524480600_bib28","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jpainsymman.2014.02.002","article-title":"Perceived discrimination in health care is associated with a greater burden of pain in sickle cell disease","volume":"48","author":"Haywood","year":"2014","journal-title":"J Pain Symptom Manage"},{"issue":"3s","key":"2026021015524480600_bib29","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.annemergmed.2020.08.013","article-title":"A survey-based needs assessment of barriers to optimal sickle cell disease care in the emergency department","volume":"76","author":"Linton","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"5","key":"2026021015524480600_bib30","doi-asserted-by":"crossref","first-page":"e206016","DOI":"10.1001\/jamanetworkopen.2020.6016","article-title":"Perceptions of US adolescents and adults with sickle cell disease on their quality of care","volume":"3","author":"Kanter","year":"1 2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"2026021015524480600_bib31","doi-asserted-by":"crossref","first-page":"e1016","DOI":"10.1542\/peds.2014-3470","article-title":"Improving the management of vaso-occlusive episodes in the pediatric emergency department","volume":"136","author":"Kavanagh","year":"2015","journal-title":"Pediatrics"},{"issue":"7","key":"2026021015524480600_bib32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.ajem.2017.11.015","article-title":"Intranasal fentanyl improves time to analgesic delivery in sickle cell pain crises","volume":"36","author":"Kelly","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"4","key":"2026021015524480600_bib33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jemermed.2016.05.042","article-title":"Emergency medicine management of sickle cell disease complications: an evidence-based update","volume":"51","author":"Simon","year":"2016","journal-title":"J Emerg Med"},{"issue":"4","key":"2026021015524480600_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.annemergmed.2013.02.004","article-title":"Emergency provider analgesic practices and attitudes toward patients with sickle cell disease","volume":"62","author":"Glassberg","year":"2013","journal-title":"Ann Emerg Med"},{"issue":"3s","key":"2026021015524480600_bib35","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.annemergmed.2020.08.006","article-title":"A multiyear cross-sectional study of guideline adherence for the timeliness of opioid administration in children with sickle cell pain crisis","volume":"76","author":"Brousseau","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"2","key":"2026021015524480600_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/08880018.2024.2437045","article-title":"The prevalence of opioid misuse diagnostic codes in children with sickle cell disease","volume":"42","author":"Tantoco","year":"2025","journal-title":"Pediatr Hematol Oncol"},{"issue":"5","key":"2026021015524480600_bib37","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00277-021-04502-2","article-title":"Opioids are not a major cause of death of patients with sickle cell disease","volume":"100","author":"Ballas","year":"2021","journal-title":"Ann Hematol"},{"issue":"11","key":"2026021015524480600_bib38","doi-asserted-by":"crossref","first-page":"e050880","DOI":"10.1136\/bmjopen-2021-050880","article-title":"Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA","volume":"11","author":"Smeltzer","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"2026021015524480600_bib39","first-page":"62","article-title":"A quality improvement initiative to improve emergency department care for pediatric patients with sickle cell disease","volume":"21","author":"Treadwell","year":"2014","journal-title":"J Clin Outcomes Manag"},{"issue":"3","key":"2026021015524480600_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jen.2014.07.014","article-title":"Safety of an ED high-dose opioid protocol for sickle cell disease pain","volume":"41","author":"Tanabe","year":"2015","journal-title":"J Emerg Nurs"},{"issue":"5","key":"2026021015524480600_bib41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1046\/j.1365-2141.2003.04193.x","article-title":"Guidelines for the management of the acute painful crisis in sickle cell disease","volume":"120","author":"Rees","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"2026021015524480600_bib42","first-page":"179","article-title":"Pain management in adult acute sickle cell pain crisis: a viewpoint","volume":"26","author":"Udezue","year":"2007","journal-title":"West Afr J Med"},{"issue":"7","key":"2026021015524480600_bib43","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0196-0644(86)80373-0","article-title":"Oral analgesia for treatment of painful crisis in sickle cell anemia","volume":"15","author":"Friedman","year":"1986","journal-title":"Ann Emerg Med"},{"issue":"3","key":"2026021015524480600_bib44","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jemermed.2006.07.022","article-title":"Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease","volume":"32","author":"Givens","year":"2007","journal-title":"J Emerg Med"},{"issue":"3","key":"2026021015524480600_bib45","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0735-6757(86)90083-5","article-title":"Management protocol for sickle-cell disease patients with acute pain: impact on emergency department and narcotic use","volume":"4","author":"Powers","year":"1986","journal-title":"Am J Emerg Med"},{"issue":"3","key":"2026021015524480600_bib46","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21847","article-title":"Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain","volume":"52","author":"Morrissey","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2026021015524480600_bib47","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ajh.26837","article-title":"Intranasal fentanyl and discharge from the emergency department among children with sickle cell disease and vaso-occlusive pain: A multicenter pediatric emergency medicine perspective","volume":"98","author":"Rees","year":"2023","journal-title":"Am J Hematol"},{"issue":"2","key":"2026021015524480600_bib48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/pbc.21781","article-title":"Healthcare utilization and expenditures for low income children with sickle cell disease","volume":"52","author":"Raphael","year":"2009","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2026021015524480600_bib49","doi-asserted-by":"crossref","first-page":"e27535","DOI":"10.1002\/pbc.27535","article-title":"Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management","volume":"66","author":"Fearon","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"2026021015524480600_bib50","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.jpain.2018.12.003","article-title":"AAAPT diagnostic criteria for acute sickle cell disease pain","volume":"20","author":"Field","year":"2019","journal-title":"J Pain"},{"issue":"5","key":"2026021015524480600_bib51","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"key":"2026021015524480600_bib52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ajem.2022.11.026","article-title":"IF IM in a crisis: intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis","volume":"64","author":"Assad","year":"2023","journal-title":"Am J Emerg Med"},{"issue":"6","key":"2026021015524480600_bib53","doi-asserted-by":"crossref","first-page":"e26332","DOI":"10.1002\/pbc.26332","article-title":"Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease","volume":"64","author":"Fein","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2026021015524480600_bib54","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1093\/pm\/pnac096","article-title":"A standardized emergency department order set decreases admission rates and in-patient length of stay for adults patients with sickle cell disease","volume":"23","author":"Wachnik","year":"2022","journal-title":"Pain Med"},{"issue":"suppl 3","key":"2026021015524480600_bib55","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.annemergmed.2020.08.008","article-title":"The effect of use of individualized pain plans in sickle cell patients presenting to the emergency department","volume":"76","author":"Della-Moretta","year":"2020","journal-title":"Ann Emerg Med"},{"key":"2026021015524480600_bib56","first-page":"93","article-title":"Impact of intranasal fentanyl in nurse initiated protocols for sickle cell vaso-occlusive pain episodes in a pediatric emergency department","author":"Akinsola","year":"2018","journal-title":"Am J Hematol"},{"issue":"4","key":"2026021015524480600_bib57","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1553-2712.2012.01330.x","article-title":"Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management","volume":"19","author":"Tanabe","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"10","key":"2026021015524480600_bib58","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1002\/pbc.25024","article-title":"Impact of individualized pain plan on the emergency management of children with sickle cell disease","volume":"61","author":"Krishnamurti","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2026021015524480600_bib59","doi-asserted-by":"crossref","first-page":"e27274","DOI":"10.1002\/pbc.27274","article-title":"A novel approach to reducing admissions for children with sickle cell disease in pain crisis through individualization and standardization in the emergency department","volume":"65","author":"Schefft","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"2026021015524480600_bib60","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.ijmedinf.2014.08.003","article-title":"Does e-pain plan improve management of sickle cell disease associated vaso-occlusive pain crisis? a mixed methods evaluation","volume":"83","author":"Kato-Lin","year":"2014","journal-title":"Int J Med Inform"},{"issue":"4","key":"2026021015524480600_bib61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/pbc.24864","article-title":"Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease","volume":"61","author":"Ender","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2026021015524480600_bib62","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"2026021015524480600_bib63","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/JHQ.0000000000000292","article-title":"Clinical pathway for vaso-occlusive pain reduces hospital admissions","volume":"44","author":"Jones","year":"2022","journal-title":"J Healthc Qual"},{"issue":"9","key":"2026021015524480600_bib64","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.7326\/M20-7171","article-title":"Treatment of acute pain in adults with sickle cell disease in an infusion center versus the emergency department : a multicenter prospective cohort study","volume":"174","author":"Lanzkron","year":"2021","journal-title":"Ann Intern Med"},{"issue":"7","key":"2026021015524480600_bib65","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/01.pec.0000280518.36408.74","article-title":"Emergency department overcrowding and children","volume":"23","author":"Hostetler","year":"2007","journal-title":"Pediatr Emerg Care"},{"issue":"3","key":"2026021015524480600_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.annemergmed.2018.11.029","article-title":"Another look at the persistent moral problem of emergency department crowding","volume":"74","author":"Moskop","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"10","key":"2026021015524480600_bib67","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/PEC.0b013e3182302871","article-title":"Emergency department crowding and analgesic delay in pediatric sickle cell pain crises","volume":"27","author":"Shenoi","year":"2011","journal-title":"Pediatr Emerg Care"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/802\/2502240\/blooda_adv-2025-016309-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/3\/802\/2502240\/blooda_adv-2025-016309-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:52:56Z","timestamp":1770756776000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/3\/802\/547925\/Intranasal-fentanyl-and-impact-of-an-emergency"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016309","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,10]]},"published":{"date-parts":[[2026,2,2]]}}}